Sotera Health Co
SHCNasdaqHealthcare · Services-Misc Health & Allied Services, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.5M | $818.2M |
| Operating income | — | $297.6M | $276.7M | $248.3M | $256.7M | $206.0M |
| Net income | $77.9M | $44.4M | $51.4M | −$233.6M | $116.9M | −$38.6M |
| Total assets | $3.26B | $3.07B | $3.13B | $3.12B | $2.79B | $2.76B |
| Total liabilities | $2.66B | $2.67B | $2.69B | $2.77B | $2.20B | $2.31B |
| Equity | $606.0M | $404.9M | $443.7M | $350.2M | $586.1M | $452.3M |
| EPS (diluted) | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.16 |
| Shares out. | 283.5M | 282.8M | 282.4M | 282.9M | 279.4M | 232.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 6.7%
- Return on equity
- 12.9%
- Return on assets
- 2.4%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 81.4%
- Debt / equity
- 4.38×
- Book value / share
- $2.14
- Revenue growth (YoY)
- 5.7%
- Net income growth (YoY)
- 75.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −6.4%clean
- Piotroski F-Score
- 5/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- High leverage (liabilities > 70% of assets)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Warburg Pincus & Co.Passive (13G)May 15, 2026
- Gtcr Investment Xi LlcPassive (13G)May 15, 2026
- Sachem Head Capital Management LpPassive (13G)May 15, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Sessa Capital (Master), L.P.Passive (13G)Feb 17, 2026
- Sculptor Capital LpPassive (13G)Feb 13, 2026
- Blackrock, Inc.Passive (13G)Jan 21, 2026
- Darsana Capital Partners LpPassive (13G)Nov 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 19.7M | 3.3 | +38.2% |
| Apr 30, 2026 | 14.3M | 6.2 | +11.3% |
| Apr 15, 2026 | 12.8M | 4.5 | +5.8% |
| Mar 31, 2026 | 12.1M | 4.2 | +14.8% |
| Mar 13, 2026 | 10.5M | 2.4 | +19.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 22, 2026
- Entered a material agreement · New financial obligationMay 20, 2026
- Terminated a material agreement · Other material eventMay 13, 2026
- Results of operations · Director / officer changeMay 5, 2026
- Director / officer changeMar 16, 2026
- Other material eventMar 6, 2026
- Results of operations · Director / officer changeFeb 24, 2026
- Director / officer changeFeb 5, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.